Summary of Aberrations in AML and ALL Patients Detected by Multiplex RT-PCR and Cytogenetic Analysis
| Aberration . | Multiplex PCR . | Cytogenetic . | ||
|---|---|---|---|---|
| AML . | ALL . | AML . | ALL . | |
| t(1;19)(q23;p13) | 0/102 | 3/62 | 0/66 | 0/45 |
| t(2;5)(p23;q35) | 1/102 | 0/62 | 0/66 | 0/45 |
| t(4;11)(q21;q23) | 0/102 | 1/62 | 0/66 | 0/45 |
| t(6;9)(q23;q34) | 2/102 | 0/62 | 1/66 | 0/45 |
| t(6;11)(q27;q23) | 2/102 | 3/62 | 0/66 | 0/45 |
| t(8;21)(q22;q22) | 8/102 | 0/62 | 2/66 | 0/45 |
| t(9;11)(q22;q23) | 1/102 | 0/62 | 0/66 | 0/45 |
| t(9;22)(q34;q11) | 3/102 | 4/62 | 0/66 | 1/45 |
| t(10;11)(p12;q23) | 2/102 | 1/62 | 2/66 | 0/45 |
| dupMLL(11q23) | 12/102 | 8/62 | — | — |
| t(11;19)(q23;p13.1) | 1/102 | 2/62 | 0/66 | 0/45 |
| t(11;19)(q23;p13.3) | 0/102 | 1/62 | 0/66 | 0/45 |
| t(12;21)(p13;q22) | 0/102 | 4/62 | — | — |
| t(15;17)(q21;q22) | 7/102 | 0/62 | 2/66 | 0/45 |
| inv(16)(p13q22) | 6/102 | 0/62 | 2/66 | 0/45 |
| t(16;21)(p11;q22) | 0/102 | 1/62 | 0/66 | 0/45 |
| Patients with numerical aberrations | — | — | 17/66 | 11/45 |
| Patients with chromosomal aberrations | 45/102 | 28/62 | 29/66 | 17/45 |
| Aberration . | Multiplex PCR . | Cytogenetic . | ||
|---|---|---|---|---|
| AML . | ALL . | AML . | ALL . | |
| t(1;19)(q23;p13) | 0/102 | 3/62 | 0/66 | 0/45 |
| t(2;5)(p23;q35) | 1/102 | 0/62 | 0/66 | 0/45 |
| t(4;11)(q21;q23) | 0/102 | 1/62 | 0/66 | 0/45 |
| t(6;9)(q23;q34) | 2/102 | 0/62 | 1/66 | 0/45 |
| t(6;11)(q27;q23) | 2/102 | 3/62 | 0/66 | 0/45 |
| t(8;21)(q22;q22) | 8/102 | 0/62 | 2/66 | 0/45 |
| t(9;11)(q22;q23) | 1/102 | 0/62 | 0/66 | 0/45 |
| t(9;22)(q34;q11) | 3/102 | 4/62 | 0/66 | 1/45 |
| t(10;11)(p12;q23) | 2/102 | 1/62 | 2/66 | 0/45 |
| dupMLL(11q23) | 12/102 | 8/62 | — | — |
| t(11;19)(q23;p13.1) | 1/102 | 2/62 | 0/66 | 0/45 |
| t(11;19)(q23;p13.3) | 0/102 | 1/62 | 0/66 | 0/45 |
| t(12;21)(p13;q22) | 0/102 | 4/62 | — | — |
| t(15;17)(q21;q22) | 7/102 | 0/62 | 2/66 | 0/45 |
| inv(16)(p13q22) | 6/102 | 0/62 | 2/66 | 0/45 |
| t(16;21)(p11;q22) | 0/102 | 1/62 | 0/66 | 0/45 |
| Patients with numerical aberrations | — | — | 17/66 | 11/45 |
| Patients with chromosomal aberrations | 45/102 | 28/62 | 29/66 | 17/45 |